Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil vs Pentoxifylline for Erectile Recovery after RALP
NCT03406169Phase 3Unknown
- Sponsor
- Brooke Army Medical Center
- Start
- Feb 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP-001 and pentoxifylline in erectile dysfunction (ED) (3 arms), sponsored by Brooke Army Medical Center. Primary endpoint: International Index of Erectile Function at 13.5 months. Status: unknown.
02
Drugs
ASP-001pentoxifylline
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03406169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03406169.